June 30, 2014 | Medigus announced the signing of a private equity placement agreement for $11.1 million, including shares and warrants. Half of the amount was raised by Migdal Insurance and Financial Holdings, and the rest by US institutional investors like Sabby Management, Armistice Capital, Senvest as well as returning investor Orbimed. Following the announcement of the investment, Medigus’ shares jumped 12.5 percent, to NIS 51.40 a pop. The proceeds from the investment spike will be used as working capital and for general management. Medigus has developed minimally invasive endoscopic devices for the treatment of GERD, one of the most common chronic diseases in the western world.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts
Israeli AI Safety Tool Among TIME’S Best Inventions For 2024
October 31, 2024
TAU Team Discovers Mechanism To Eliminate Cancerous Tumors
October 30, 2024
Ashdod Port Investing In Startups As Part Of Innovation Strategy
October 29, 2024
BGU Develops Fast Fact Checking Via News Sources Not People
October 28, 2024
Facebook comments